SELLAS Life Sciences Group (SLS) EPS (Weighted Average and Diluted): 2020-2023
Historic EPS (Weighted Average and Diluted) for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$0.25.
- SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) rose 41.86% to -$0.25 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.36, marking a year-over-year increase of 39.01%. This contributed to the annual value of -$1.34 for FY2023, which is 37.09% up from last year.
- Per SELLAS Life Sciences Group's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.25 for Q4 2023, which was up 24.24% from -$0.33 recorded in Q3 2023.
- In the past 5 years, SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) ranged from a high of -$0.16 in Q1 2021 and a low of -$1.05 during Q1 2022.
- For the 3-year period, SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) averaged around -$0.41, with its median value being -$0.38 (2022).
- Per our database at Business Quant, SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) crashed by 556.25% in 2022 and then spiked by 55.24% in 2023.
- SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.28 in 2020, then tumbled by 50.00% to -$0.42 in 2021, then dropped by 2.38% to -$0.43 in 2022, then skyrocketed by 41.86% to -$0.25 in 2023.
- Its EPS (Weighted Average and Diluted) was -$0.25 in Q4 2023, compared to -$0.33 in Q3 2023 and -$0.31 in Q2 2023.